William Ondo Download Headshot

William G. Ondo, MD

  • Houston Methodist neurologist
  • Director, Houston Methodist Movement Disorders Clinic
Media Contact: Ashley White , 832.652.1173

William G. Ondo, MD

Request Interview
Media Contact: Ashley White , 832.652.1173

Areas of Expertise

  • Botulinum toxin administration
  • Dystonia
  • Huntington’s disease
  • Movement disorders
  • Parkinson’s disease
  • Restless leg syndrome
  • Tardive dyskinesia
  • Tourette’s syndrome
  • Tremors

Credentials

BOARD CERTIFICATION
American Board of Psychiatry and Neurology, Neurology
BOARD CERTIFICATION
American Board of Psychiatry and Neurology, Sleep Medicine
MEDICAL SCHOOL
University of Virginia School of Medicine, Charlottesville, Virginia | 1991
INTERNSHIP
University of North Carolina Hospital, Chapel Hill, North Carolina
FELLOWSHIP
Movement Disorders, Baylor College of Medicine, Houston, Texas
RESIDENCY
Neurology, Duke University Medical Center, Durham, North Carolina

Publications

Rethinking clinical trials in restless legs syndrome: A roadmap
Garcia-Borreguero, D, Black, J, Earley, CJ, Fulda, S, Högl, B, Manconi, M, Ondo, W, Roth, T, Trenkwalder, C & Winkelman, JW 2024, , Sleep Medicine Reviews, vol. 77, 101978. https://doi.org/10.1016/j.smrv.2024.101978


The Clinician’s Tardive Inventory (CTI): A New Clinical Tool for Documenting and Rating Tardive Dyskinesia
Trosch, RM, Comella, CL, Caroff, SN, Ondo, WG, Shillington, AC, LaChappelle, BJ, Hauser, RA, Correll, CU & Friedman, JH 2024, , Journal of Clinical Psychiatry, vol. 85, no. 1, 14886. https://doi.org/10.4088/JCP.23m14886

Review of the role of the endogenous opioid and melanocortin systems in the restless legs syndrome
Walters, AS, Li, Y, Koo, BB, Ondo, WG, Weinstock, LB, Champion, D, Afrin, LB, Karroum, EG, Bagai, K & Spruyt, K 2024, , Brain, vol. 147, no. 1, pp. 26-38. https://doi.org/10.1093/brain/awad283

A Randomized Phase 2 KINETIC Trial Evaluating SAGE-324/BIIB124 in Individuals with Essential Tremor
Elble, RJ, Ondo, WG, Lyons, KE, Qin, M, Garafola, S, Hersh, B, Lieu, TM, Arkilo, D, Chuang, R, Bankole, K & Pahwa, R 2024, , Movement Disorders, vol. 39, no. 4, pp. 733-738. https://doi.org/10.1002/mds.29731

Sex Differences in Dystonia
Kilic-Berkmen, G, Scorr, LM, McKay, L, Thayani, M, Donsante, Y, Perlmutter, JS, Norris, SA, Wright, L, Klein, C, Feuerstein, JS, Mahajan, A, Wagle-Shukla, A, Malaty, I, LeDoux, MS, Pirio-Richardson, S, Pantelyat, A, Moukheiber, E, Frank, S, Ondo, W, Saunders-Pullman, R, Lohman, K, Hess, EJ & Jinnah, HA 2024, , Movement Disorders Clinical Practice, vol. 11, no. 8, pp. 973-982. https://doi.org/10.1002/mdc3.14059

Orthostatic hypotension and subjective symptomatic orthostasis in Parkinson's disease: Associations and correlations
Heisler, JM, Toledo-Atucha, J, Lin, CC, Patel, HN & Ondo, WG 2024, , Clinical Parkinsonism and Related Disorders, vol. 11, 100262. https://doi.org/10.1016/j.prdoa.2024.100262

Apomorphine titration with and without anti-emetic pretreatment in patients with Parkinson's disease experiencing OFF episodes: A modified Delphi panel
Isaacson, SH, Dewey, R, Hauser, RA, Kremens, D, Kumar, R, Lew, M, Ondo, W, Pagan, F, Lyons, KE & Pahwa, R 2024, , Clinical Parkinsonism and Related Disorders, vol. 11, 100264, pp. 100264. https://doi.org/10.1016/j.prdoa.2024.100264

The Self-Administered Screening Questionnaire for Parkinson's Disease-Associated Psychosis (SASPAP)
Koneru, V, Espay, AJ, Cole, AJ, Weintraub, D, Crist, K, Pascual, MB & Ondo, WG 2023, , Movement disorders : official journal of the Movement Disorder Society, vol. 38, no. 11, pp. 1982-1987. https://doi.org/10.1002/mds.29627

IPX203 vs Immediate-Release Carbidopa-Levodopa for the Treatment of Motor Fluctuations in Parkinson Disease: The RISE-PD Randomized Clinical Trial
Hauser, RA, Espay, AJ, Ellenbogen, AL, Fernandez, HH, Isaacson, SH, Lewitt, PA, Ondo, WG, Pahwa, R, Schwarz, J, Stocchi, F, Zeitlin, L, Banisadr, G, Fisher, S, Visser, H & DSouza, R 2023, , JAMA Neurology, vol. 80, no. 10, pp. 1062-1069. https://doi.org/10.1001/jamaneurol.2023.2679


Dose Optimization of Apomorphine Sublingual Film for off Episodes in Parkinson's Disease: Is the Prophylactic Use of an Antiemetic Necessary?
Hauser, RA, Ondo, WG, Zhang, Y, Bowling, A, Navia, B, Pappert, E & Isaacson, SH 2023, , Journal of Parkinsons disease, vol. 13, no. 3, pp. 403-414. https://doi.org/10.3233/JPD-223537

Clozapine: Efficacy for Parkinson Disease psychosis in patients refractory to pimavanserin
Thames, BH & Ondo, WG 2023, , Parkinsonism and Related Disorders, vol. 109, 105356, pp. 105356. https://doi.org/10.1016/j.parkreldis.2023.105356

Task Specific Tremor in Parkinson’s Disease Responds to Apomorphine
Ondo, WG, Koneru, V & Arif, C 2023, , Tremor and Other Hyperkinetic Movements, vol. 13, no. 1, 20, pp. 20. https://doi.org/10.5334/tohm.764

The Self-Administered Screening Questionnaire for Parkinson's Disease-Associated Psychosis (SASPAP)
Koneru, V, Espay, AJ, Cole, AJ, Weintraub, D, Crist, K, Pascual, MB & Ondo, WG 2023, , Movement Disorders, vol. 38, no. 11, pp. 1982-1987. https://doi.org/10.1002/mds.29627

An Empirical Comparison of Commonly Used Universal Rating Scales for Dystonia
Boz, D, Kilic-Berkmen, G, Perlmutter, JS, Norris, SA, Wright, LJ, Klein, C, Bäumer, T, Löns, S, Feuerstein, JS, Mahajan, A, Wagle-Shukla, A, Malaty, I, LeDoux, MS, Ondo, W, Pantelyat, A, Frank, S, Saunders-Pullman, R & Jinnah, HA 2023, , Movement Disorders Clinical Practice, vol. 10, no. 12, pp. 1777-1786. https://doi.org/10.1002/mdc3.13909


Consensus guidelines on the construct validity of rodent models of restless legs syndrome
the International Restless Legs Syndrome Study Group (IRLSSG) 2022, , DMM Disease Models and Mechanisms, vol. 15, no. 8, dmm049615. https://doi.org/10.1242/dmm.049615

Tremor rating scales and laboratory tools for assessing tremor
Elble, RJ & Ondo, W 2022, , Journal of the Neurological Sciences, vol. 435, 120202, pp. 120202. https://doi.org/10.1016/j.jns.2022.120202


Languages

  • English